
Allergy Immunotherapy Market Share, Demand, Outlook and Futhur Opportunities
Allergy Immunotherapy Market Growth, Size, Trends Analysis - By Treatment Type, By Type, By Allergy Type, By Distribution Channel - Regional Outlook, Competitive Strategies and Segment Forecast to 2034
Published: Feb-2025 | Report ID: HLCA2555 | Pages: 1 - 221 | Formats*: |
Category : Healthcare |


- Viatris and Lexicon Pharmaceuticals signed a deal in October 2024, giving Viatris the rights to sell sotagliflozin in all markets outside of the US and Europe. Approved in May 2023, sotagliflozin is intended to lower cardiovascular risks in patients with type 2 diabetes and heart failure. Viatris will manage all regulatory and commercialization activities, and the agreement includes an upfront payment of USD 25 million as well as possible milestone payments.
- Merck and Siemens fortified their collaboration in September 2024 by signing a Memorandum of Understanding to boost smart manufacturing, which integrates cutting-edge technologies for better manufacturing procedures. This partnership seeks to use modular production to expedite product development while giving sustainability and adaptability first priority. Merck is anticipated to use cutting-edge hardware and software solutions to minimize time-to-market and streamline operations by utilizing the Siemens Xcelerator platform.
Report Metric | Details |
Market size available for years | 2021-2034 |
Base year considered | 2024 |
Forecast period | 2025-2034 |
Segments covered | By Treatment Type, By Type, By Allergy Type, By Distribution Channel. |
Regions covered | North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa. |
Companies Covered | ALK-Abelló A/S, Allergy Therapeutics, ASIT Biotech, Circassia, DESENTUM OY, DMK Pharmaceuticals, DVB Technologies SA, HAL Allergy B.V., HollisterStier Allergy, LETIPharma, and others. |
- Global Allergy Immunotherapy Market Size (FY’2021-FY’2034)
- Overview of Global Allergy Immunotherapy Market
- Segmentation of Global Allergy Immunotherapy Market By Treatment Type (Subcutaneous Immunotherapy, Sublingual Immunotherapy)
- Segmentation of Global Allergy Immunotherapy Market By Type (Tablets, Drops)
- Segmentation of Global Allergy Immunotherapy Market By Allergy Type, (Allergic Rhinitis, Allergic Asthma, Others)
- Segmentation of Global Allergy Immunotherapy Market By Distribution Channel, (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy)
- Statistical Snap of Global Allergy Immunotherapy Market
- Expansion Analysis of Global Allergy Immunotherapy Market
- Problems and Obstacles in Global Allergy Immunotherapy Market
- Competitive Landscape in the Global Allergy Immunotherapy Market
- Details on Current Investment in Global Allergy Immunotherapy Market
- Competitive Analysis of Global Allergy Immunotherapy Market
- Prominent Players in the Global Allergy Immunotherapy Market
- SWOT Analysis of Global Allergy Immunotherapy Market
- Global Allergy Immunotherapy Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1.1. Scope of the report1.2. Market segment analysis
2.1. Research data source
2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPERs internal database2.1.4. Premium insight from KOLs
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges
5.1. SWOT Analysis
5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape
5.3. PORTERs Five Forces
5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6.1. Global Allergy Immunotherapy Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Allergy Immunotherapy Market
7.1. Subcutaneous Immunotherapy7.2. Sublingual Immunotherapy
8.1. Tablets8.2. Drops
9.1. Allergic Rhinitis9.2. Allergic Asthma9.3. Others
10.1. Hospital Pharmacy10.2. Retail Pharmacy10.3. Online Pharmacy
11.1. Global Allergy Immunotherapy Market Size and Market Share
12.1. Asia-Pacific
12.1.1. Australia12.1.2. China12.1.3. India12.1.4. Japan12.1.5. South Korea12.1.6. Rest of Asia-Pacific
12.2. Europe
12.2.1. France12.2.2. Germany12.2.3. Italy12.2.4. Spain12.2.5. United Kingdom12.2.6. Rest of Europe
12.3. Middle East and Africa
12.3.1. Kingdom of Saudi Arabia12.3.2. United Arab Emirates12.3.3. Qatar12.3.4. South Africa12.3.5. Egypt12.3.6. Morocco12.3.7. Nigeria12.3.8. Rest of Middle-East and Africa
12.4. North America
12.4.1. Canada12.4.2. Mexico12.4.3. United States
12.5. Latin America
12.5.1. Argentina12.5.2. Brazil12.5.3. Rest of Latin America
13.1. ALK-Abello A/S
13.1.1. Company details13.1.2. Financial outlook13.1.3. Product summary13.1.4. Recent developments
13.2. Allergy Therapeutics
13.2.1. Company details13.2.2. Financial outlook13.2.3. Product summary13.2.4. Recent developments
13.3. ASIT Biotech
13.3.1. Company details13.3.2. Financial outlook13.3.3. Product summary13.3.4. Recent developments
13.4. Circassia
13.4.1. Company details13.4.2. Financial outlook13.4.3. Product summary13.4.4. Recent developments
13.5. DESENTUM OY
13.5.1. Company details13.5.2. Financial outlook13.5.3. Product summary13.5.4. Recent developments
13.6. DMK Pharmaceuticals
13.6.1. Company details13.6.2. Financial outlook13.6.3. Product summary13.6.4. Recent developments
13.7. DVB Technologies SA
13.7.1. Company details13.7.2. Financial outlook13.7.3. Product summary13.7.4. Recent developments
13.8. HAL Allergy B.V.
13.8.1. Company details13.8.2. Financial outlook13.8.3. Product summary13.8.4. Recent developments
13.9. HollisterStier Allergy
13.9.1. Company details13.9.2. Financial outlook13.9.3. Product summary13.9.4. Recent developments
13.10. LETIPharma
13.10.1. Company details13.10.2. Financial outlook13.10.3. Product summary13.10.4. Recent developments
13.11. Others
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment






Related Reports
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.